Year: 2025
Type: editorial
Abstract: following his battle with Amyotrophic Lateral Sclerosis (ALS).It is very ironic that after teaching pharmacists, doctors, Ph.D. students, undergraduates, and mentoring junior professors for almost 50 years about diseases and medications, he succumbed to a disease with few remedies or medications.With the assistance of several other friends of Bob's, we have put together an editorial that reflects his contributions and the high respect he had from his peers.
Source: Chemical Research in Toxicology
Authors: John R. Cashman, Matthew A. Cerny
Institutions: Human BioMolecular Research Institute, Pfizer (United States)
Language: English
Subfield: History and Philosophy of Science
Field: Arts and Humanities
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4410506216